FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "MedicinalProductDefinition",
  "id": "Padcev-30mg-Powder",
  "meta": {
    "profile": [
      "http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-medicinalproductdefinition"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://fhir.ch/ig/ch-idmp/StructureDefinition/authorizedDoseForm",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://standardterms.edqm.eu",
            "code": "11215000",
            "display": "Lyophilisate for solution for infusion"
          }
        ]
      }
    }
  ],
  "identifier": [
    {
      "system": "http://fhir.ch/ig/ch-idmp/sid/mpid",
      "value": "CH-01100869-0682910040000"
    }
  ],
  "indication": "Padcev ist indiziert zur Behandlung von Erwachsenen mit lokal fortgeschrittenem oder metastasiertem Urothelkarzinom (mUC), die eine platinhaltige Chemotherapie im neoadjuvanten/adjuvanten, lokal fortgeschrittenen oder metastasierten Setting erhalten haben und die während oder nach der Behandlung mit einem Inhibitor des programmierten Zelltodrezeptors-1 (PD-1) oder des programmierten Zelltod-Liganden 1 (PD-L1) einen Progress oder einen Rückfall der Erkrankung erlitten haben.",
  "legalStatusOfSupply": {
    "coding": [
      {
        "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-legal-status-of-supply",
        "code": "756005034000001",
        "display": "A: Single dispensing requiring a medical or veterinary prescription"
      }
    ]
  },
  "additionalMonitoringIndicator": {
    "coding": [
      {
        "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-additional-monitoring-indicator",
        "code": "756005001003",
        "display": "No Warning"
      }
    ]
  },
  "pediatricUseIndicator": {
    "coding": [
      {
        "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-pediatric-use-indicator",
        "code": "756005003002",
        "display": "Not authorised for the treatment in children"
      }
    ]
  },
  "classification": [
    {
      "coding": [
        {
          "system": "http://www.whocc.no/atc",
          "code": "L01EX13"
        }
      ]
    },
    {
      "coding": [
        {
          "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-authorisation-category",
          "code": "756005011000005",
          "display": "NA KAS art. 12 para. 5 TPLO"
        }
      ]
    },
    {
      "coding": [
        {
          "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-MedicinalProductCategory",
          "code": "756005039000003",
          "display": "Biologics"
        }
      ]
    }
  ],
  "marketingStatus": [
    {
      "country": {
        "coding": [
          {
            "system": "urn:iso:std:iso:3166",
            "code": "CH",
            "display": "Switzerland"
          }
        ]
      },
      "status": {
        "coding": [
          {
            "system": "http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-marketing-status",
            "code": "7560050074000003",
            "display": "No interruption of distribution reported"
          }
        ]
      },
      "dateRange": {
        "start": "2011-09-11"
      }
    }
  ],
  "attachedDocument": [
    {
      "reference": "DocumentReference/DocRef-FI-Padcev"
    }
  ],
  "name": [
    {
      "productName": "Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung",
      "usage": [
        {
          "country": {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "CH",
                "display": "Switzerland"
              }
            ]
          },
          "language": {
            "coding": [
              {
                "system": "urn:ietf:bcp:47",
                "code": "de-CH"
              }
            ]
          }
        }
      ]
    }
  ]
}